These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16246040)

  • 1. Insulin and cognitive function in humans: experimental data and therapeutic considerations.
    Strachan MW
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1037-40. PubMed ID: 16246040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
    Reger MA; Watson GS; Green PS; Wilkinson CW; Baker LD; Cholerton B; Fishel MA; Plymate SR; Breitner JC; DeGroodt W; Mehta P; Craft S
    Neurology; 2008 Feb; 70(6):440-8. PubMed ID: 17942819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease.
    Watson GS; Craft S
    Eur J Pharmacol; 2004 Apr; 490(1-3):97-113. PubMed ID: 15094077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis.
    Watson GS; Craft S
    J Neurol Sci; 2006 Jun; 245(1-2):21-33. PubMed ID: 16631207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal insulin to improve memory function in humans.
    Benedict C; Hallschmid M; Schultes B; Born J; Kern W
    Neuroendocrinology; 2007; 86(2):136-42. PubMed ID: 17643054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal insulin improves memory in humans.
    Benedict C; Hallschmid M; Hatke A; Schultes B; Fehm HL; Born J; Kern W
    Psychoneuroendocrinology; 2004 Nov; 29(10):1326-34. PubMed ID: 15288712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor during hypoglycemia in patients with type 1 diabetes mellitus: relation to cognitive function and renin-angiotensin system activity.
    Kristensen PL; Høi-Hansen T; Boomsma F; Pedersen-Bjergaard U; Thorsteinsson B
    Metabolism; 2009 Oct; 58(10):1430-8. PubMed ID: 19573885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal insulin as a therapeutic option in the treatment of cognitive impairments.
    Benedict C; Frey WH; Schiöth HB; Schultes B; Born J; Hallschmid M
    Exp Gerontol; 2011; 46(2-3):112-5. PubMed ID: 20849944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The measurement of cognitive function during acute hypoglycaemia: experimental limitations and their effect on the study of hypoglycaemia unawareness.
    Heller SR; Macdonald IA
    Diabet Med; 1996 Jul; 13(7):607-15. PubMed ID: 8840093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism.
    Ott V; Benedict C; Schultes B; Born J; Hallschmid M
    Diabetes Obes Metab; 2012 Mar; 14(3):214-21. PubMed ID: 21883804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free insulin-like growth factor-I and cognitive function in older persons living in community.
    Landi F; Capoluongo E; Russo A; Onder G; Cesari M; Lulli P; Minucci A; Pahor M; Zuppi C; Bernabei R
    Growth Horm IGF Res; 2007 Feb; 17(1):58-66. PubMed ID: 17208483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans.
    Stockhorst U; de Fries D; Steingrueber HJ; Scherbaum WA
    Physiol Behav; 2004 Oct; 83(1):47-54. PubMed ID: 15501490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose improvement of memory: a review.
    Messier C
    Eur J Pharmacol; 2004 Apr; 490(1-3):33-57. PubMed ID: 15094072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease.
    Watson GS; Bernhardt T; Reger MA; Cholerton BA; Baker LD; Peskind ER; Asthana S; Plymate SR; Frölich L; Craft S
    Neurobiol Aging; 2006 Jan; 27(1):38-41. PubMed ID: 16298239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
    Rakover I; Arbel M; Solomon B
    Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
    Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H
    Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF APPs alpha and phosphorylated tau protein levels in mild cognitive impairment and dementia of Alzheimer's type.
    Fellgiebel A; Kojro E; Müller MJ; Scheurich A; Schmidt LG; Fahrenholz F
    J Geriatr Psychiatry Neurol; 2009 Mar; 22(1):3-9. PubMed ID: 19073834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial.
    Schmidt H; Kern W; Giese R; Hallschmid M; Enders A
    J Med Genet; 2009 Apr; 46(4):217-22. PubMed ID: 18948358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral insulin and brain structure in early Alzheimer disease.
    Burns JM; Donnelly JE; Anderson HS; Mayo MS; Spencer-Gardner L; Thomas G; Cronk BB; Haddad Z; Klima D; Hansen D; Brooks WM
    Neurology; 2007 Sep; 69(11):1094-104. PubMed ID: 17846409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Links between cognitive impairment in insulin resistance: an explanatory model.
    Convit A
    Neurobiol Aging; 2005 Dec; 26 Suppl 1():31-5. PubMed ID: 16246463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.